The US FDA has provided a complete response letter for Daiichi Sankyo and MSD’s ...
AbbVie has announced the receipt of accelerated approval from the US FDA for EPK...
As the funding market evolves, there is greater emphasis on companies having com...
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest ...
Ohtuvayre is expected to rake in $1.1bn in global sales from the market for COPD...
The recent raise will bring the biotech accelerator Curie.Bio’s total funds rais...
Data showed that Ohtuvayre significantly improved dyspnea compared to placebo in...
Formation Bio has secured $372m in Series D funding to bolster its drug pipeline...
The CDC ACIP has recommended the routine use of respiratory syncytial virus (RSV...
ETH47 is a type III interferon-encoding mRNA drug that could be used to treat re...
Merck’s decision follows the independent committee's analysis that the trial is ...
Oncoinvent has received FDA fast track designation for its therapy, Radspherin, ...
Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV27...
GSK has received approval from the Japan's Ministry of Health, Labour and Welfar...
Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to co...
Explore the critical aspects of pharma packaging solutions, design, and companie...
